Perigon Wealth Management »

Crispr Therapeutics shares owned by Perigon Wealth Management

Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Perigon Wealth Management from 13F filings

Historical chart of Perigon Wealth Management investment in Crispr Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Crispr Therapeutics held by Perigon Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crispr Therapeutics by Perigon Wealth Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $1.0M 15k 68.16
2023-12-31 $934k 15k 62.60
2023-09-30 $650k 14k 45.39
2023-06-30 $639k 11k 56.14
2023-03-31 $524k 12k 45.23
2022-12-31 $486k 12k 40.65
2022-09-30 $789k 12k 65.36
2022-06-30 $722k 12k 60.75
2022-03-31 $661k 11k 62.78
2021-12-31 $656k 8.7k 75.72
2021-09-30 $813k 7.3k 111.89
2021-06-30 $1.1M 6.8k 161.83
2021-03-31 $784k 6.4k 121.78
2020-12-31 $859k 5.6k 153.17
2020-09-30 $424k 5.1k 83.63
2020-06-30 $362k 4.9k 73.47
2020-03-31 $291k 6.4k 45.81
2019-12-31 $278k 4.6k 60.03
2011-09-30 $789k 12k 65.36